ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 171 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $106,516 | -20.1% | 33,601 | +24.4% | 0.00% | – |
Q1 2023 | $133,380 | -31.2% | 27,000 | -12.4% | 0.00% | – |
Q4 2022 | $193,845 | -41.6% | 30,818 | +0.3% | 0.00% | -100.0% |
Q3 2022 | $332,000 | -5.1% | 30,725 | +0.0% | 0.00% | 0.0% |
Q2 2022 | $350,000 | +50.2% | 30,713 | +20.0% | 0.00% | – |
Q1 2022 | $233,000 | -39.2% | 25,600 | -0.3% | 0.00% | -100.0% |
Q4 2021 | $383,000 | -41.8% | 25,666 | +0.3% | 0.00% | 0.0% |
Q3 2021 | $658,000 | -1.5% | 25,600 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $668,000 | -25.4% | 25,600 | +1.0% | 0.00% | -50.0% |
Q1 2021 | $895,000 | +36.4% | 25,351 | -2.5% | 0.00% | +100.0% |
Q4 2020 | $656,000 | -33.5% | 26,000 | -0.6% | 0.00% | -66.7% |
Q3 2020 | $986,000 | -13.3% | 26,150 | -1.5% | 0.00% | 0.0% |
Q2 2020 | $1,137,000 | +125.1% | 26,550 | +2.1% | 0.00% | +50.0% |
Q1 2020 | $505,000 | -25.2% | 26,000 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $675,000 | -4.8% | 26,000 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $709,000 | +5.7% | 26,000 | +4.0% | 0.00% | 0.0% |
Q2 2019 | $671,000 | -7.2% | 25,000 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $723,000 | +32.9% | 25,000 | +23.8% | 0.00% | +50.0% |
Q4 2018 | $544,000 | – | 20,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |